Andan, Erlinda .

HRN: 25-34-83  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/30/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/30/2024
07/07/2024
IV
2.25gms
Q8
CAP MR

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Non-compliant To Guidelines